GRL-0617, 98%, a potent, selective and competitive noncovalent inhibitor of severe acute respiratory syndrome (SARS-CoV) papain-like protease (PLpro)/deubiquitinase, with an IC50 of 0.6 μM, and with a Ki of 0.49 μM
GRL-0617
MW : 304.39
CAS : 1093070-16-6
EC号 : 304.39